Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 known ✓ | P00519 | 1/20 | 0.43 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.43 |
| ▸ | PDGFRB known ✓ | P09619 | 1/20 | 0.43 |
| ▸ | KIT known ✓ | P10721 | 1/20 | 0.43 |
| ▸ | BRAF known ✓ | P15056 | 1/20 | 0.43 |
| ▸ | FLT1 known ✓ | P17948 | 1/20 | 0.43 |
| ▸ | FLT4 known ✓ | P35916 | 1/20 | 0.43 |
| ▸ | KDR known ✓ | P35968 | 1/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 4/20 | 0.50 |
| ▸ | MAPK14 | Q16539 | 12/20 | 0.49 |
| ▸ | MAPK12 | P53778 | 7/20 | 0.49 |
| ▸ | MAPK13 | O15264 | 6/20 | 0.49 |
| ▸ | MAPK11 | Q15759 | 6/20 | 0.49 |
| ▸ | DDR2 | Q16832 | 2/20 | 0.49 |
| ▸ | TNF | P01375 | 2/20 | 0.44 |
| ▸ | HCK | P08631 | 2/20 | 0.43 |
| ▸ | CIT | O14578 | 1/20 | 0.43 |
| ▸ | MUSK | O15146 | 1/20 | 0.43 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.43 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3393244 | 0.89 | MAPK14 (0.58) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3393220 | 0.89 | MAPK14 (0.52) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3389417 | 0.89 | MAPK14 (0.52) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3391106 | 0.88 | MAPK14 (0.51) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3393757 | 0.88 | PTK2B (0.54) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3394249 | 0.87 | PTK2B (0.56) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3422287 | 0.87 | MAPK14 (0.55) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3392093 | 0.86 | PTK2B (0.56) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3394292 | 0.86 | PTK2B (0.56) | PTK2BMAPK14MAPK12MAPK13MAPK11 | |
| SCHEMBL3394260 | 0.85 | PTK2B (0.52) | PTK2BMAPK14MAPK12MAPK13MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1943243-B1 | KINASE INHIBITORS | LILLY CO ELI (US) | 2010-12-29 | — | — | EP | disclosed |